SCHEMBL3831373

SCHEMBL3831373

CC(=O)OC(C)OC(=O)C(CCCCCCC(=O)O)C(C)OC(C)=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 2/20 0.38
FFAR1 O14842 2/20 0.38
ALDH1A1 P00352 4/20 0.37
GSTK1 Q9Y2Q3 1/20 0.36
TRPV1 Q8NER1 1/20 0.36
TSHR P16473 4/20 0.35
LMNA P02545 1/20 0.35
NFKB1 P19838 1/20 0.35
PMP22 Q01453 1/20 0.35
BHMT Q93088 1/20 0.35
PPARG P37231 5/20 0.34
PPARD Q03181 5/20 0.34
PPARA Q07869 5/20 0.34
HDAC11 Q96DB2 4/20 0.34
GPR84 Q9NQS5 3/20 0.34
TLR2 O60603 2/20 0.34
TDP1 Q9NUW8 2/20 0.34
FABP4 P15090 2/20 0.34
PTPN1 P18031 2/20 0.34
SLC22A6 Q4U2R8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4383441 1.00 FFAR4 (0.38) FFAR4FFAR1ALDH1A1GSTK1TRPV1
SCHEMBL4394774 1.00 FFAR4 (0.38) FFAR4FFAR1ALDH1A1GSTK1TRPV1
SCHEMBL4393824 1.00 FFAR4 (0.38) FFAR4FFAR1ALDH1A1GSTK1TRPV1
SCHEMBL4384712 1.00 FFAR4 (0.38) FFAR4FFAR1ALDH1A1GSTK1TRPV1
SCHEMBL4383298 0.98 FFAR4 (0.36) FFAR4FFAR1ALDH1A1GSTK1TRPV1
SCHEMBL4389902 0.94 ENPEP (0.32) GSTK1TRPV1TSHRBHMTPTPN1
SCHEMBL4388239 0.84 ALDH1A1 (0.38) FFAR4FFAR1ALDH1A1GSTK1TSHR
SCHEMBL4395469 0.84 ALDH1A1 (0.38) FFAR4FFAR1ALDH1A1GSTK1TSHR
SCHEMBL4386107 0.84 ALDH1A1 (0.38) FFAR4FFAR1ALDH1A1GSTK1TSHR
SCHEMBL4388242 0.84 ALDH1A1 (0.38) FFAR4FFAR1ALDH1A1GSTK1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7629383-B2 Double esters DRUG DISCOVERY LABORATORY AS (NO) 2009-12-08 US disclosed
EP-1448508-B1 DOUBLE ESTERS DRUG DISCOVERY LAB AS (NO) 2009-09-23 EP disclosed
US-20050203181-A1 Double esters DRUG DISCOVERY LABORATORY AS (NO) 2005-09-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050203181-A1 Double esters ACACA, CES1, ACACB FFAR4 80/4885FFAR1 87/4885ALDH1A1 296/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.